St George Mining Limited (ASX:SGQ) Secures A$8M Investment for Araxá Project
St George Mining Limited (ASX:SGQ) secures a A$8 million investment and strategic EPC partnership for the Araxá Niobium-REE Project in Brazil.
EDU Holdings Limited (ASX:EDU) Reports Term 1 2025 Enrolments
EDU Holdings Limited (ASX:EDU) reports a 35% increase in Term 1 2025 enrolments, demonstrating strong demand amid regulatory changes.
Dexus Industria REIT (ASX:DXI) Reports Half-Year Financial Results
Dexus Industria REIT (ASX:DXI) posts a net profit of $53.7 million for the half-year, driven by increased FFO and maintaining steady distributions.
Eagle Mountain Mining (ASX:EM2) Raises $1.62M in Entitlement Offer
Eagle Mountain Mining (ASX:EM2) raises $1.62 million in its entitlement offer to advance key exploration projects.
Lincoln Minerals Limited (ASX:LML) Expands Copper & Base Metals Potential at Minbrie, SA
Lincoln Minerals (ASX:LML) expands copper and base metals potential at Minbrie, SA, unveiling a two-phase exploration plan.
Evolution Mining Limited (ASX:EVN) Reports Record H1 FY25 Financials and 250% Dividend Increase
Evolution Mining (ASX:EVN) reports record H1 FY25 profits and a 250% dividend increase, highlighting strong operational performance.
Arika Resources Limited (ASX:ARI) Discovers 4.5km of Gold-Bearing Quartz Reefs at Yundamindra
Arika Resources (ASX:ARI) discovers over 4.5km of gold-bearing quartz reefs at Yundamindra, underscoring significant exploration potential.
AGL Energy Limited (ASX:AGL) Reports 15.3% Revenue Growth, Declares Interim Dividend
AGL Energy Limited (ASX:AGL) reports a 15.3% revenue increase for H1 2024 and declares a 23.0 cents interim dividend.
Felix Gold Limited (ASX:FXG) Announces High-Grade Antimony Results
Felix Gold Limited (ASX:FXG) reports exceptional high-grade antimony results from Treasure Creek Project, including 3m at 50.26% Sb and 5.29 g/t Au.
EMVision Medical Devices (ASX:EMV) Secures US Ethics Approval for Pivotal Trial
EMVision Medical Devices (ASX:EMV) receives US IRB approval for pivotal trial of the emu™ brain scanner, maintaining progress towards March 2025 activation.